Peter J. Hotez, Maria Elena Bottazzi: Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. In: Annual Review of Medicine. Band73, Nr.1, 27. Januar 2022, ISSN0066-4219, S.55–64, doi:10.1146/annurev-med-042420-113212 (annualreviews.org [abgerufen am 21. Oktober 2022]).
Peter J. Hotez, Maria Elena Bottazzi: Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. In: Annual Review of Medicine. Band73, Nr.1, 27. Januar 2022, ISSN0066-4219, S.55–64, doi:10.1146/annurev-med-042420-113212 (annualreviews.org [abgerufen am 21. Oktober 2022]).
Szu-Min Hsieh et al.: Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. In: The Lancet. Respiratory Medicine. Band9, Nr.12, Dezember 2021, S.1396–1406, doi:10.1016/S2213-2600(21)00402-1, PMID 34655522, PMC 8514195 (freier Volltext) – (englisch).
Szu-Min Hsieh et al.: Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan. In: The Lancet. Respiratory Medicine. Band9, Nr.12, Dezember 2021, S.1396–1406, doi:10.1016/S2213-2600(21)00402-1, PMID 34655522, PMC 8514195 (freier Volltext) – (englisch).
Peter J. Hotez, Maria Elena Bottazzi: Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. In: Annual Review of Medicine. Band73, Nr.1, 27. Januar 2022, ISSN0066-4219, S.55–64, doi:10.1146/annurev-med-042420-113212 (annualreviews.org [abgerufen am 21. Oktober 2022]).